Bayer, Regeneron To Launch Phase III Trials Of Diabetes Eye Drug In Asia
This article was originally published in PharmAsia News
Executive Summary
Bayer HealthCare and Regeneron Pharmaceuticals plan joint Phase III trials of an eye treatment for diabetics in several Asian countries, including China and Russia.